MIRM SCHEDULE 13G/A: SEC filing
Janus Henderson Group Ltd.
Filed with the SEC on · accession 0001274173-26-000242
MIRM filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -2.6% by the first close after the filing.
Summary of the filing
Janus Henderson Group Ltd. filed an amended Schedule 13G reporting beneficial ownership of 5,537,330 shares (8.5%) of Mirum Pharmaceuticals common stock as of September 30, 2026, held through its asset manager subsidiaries on behalf of managed portfolios.
Key details
How MIRM stock reacted
Close before
$93.99
Nov 13, 2026
First close after
-2.56%
$91.58
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for MIRM, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for MIRM?
Click hereFrequently asked questions
What did MIRM file with the SEC on Nov 16, 2026?
MIRM filed a SCHEDULE 13G/A (SEC filing). Janus Henderson Group Ltd. filed an amended Schedule 13G reporting beneficial ownership of 5,537,330 shares (8.5%) of Mirum Pharmaceuticals common stock as of September 30, 2026, held through its asset manager subsidiaries on behalf of managed portfolios.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did MIRM stock react to this filing?
MIRM closed at $93.99 before the filing and $91.58 on Nov 16, 2026 (-2.56%).
Other MIRM SEC filings
- 8-K · Fda approvalNov 10, 2026
- 10-Q · Executive departureNov 3, 2026
- 8-K · SEC filingNov 3, 2026
- 8-K · Fda approvalOct 26, 2026
- 8-K · Fda approvalOct 13, 2026
- 8-K · Fda approvalSep 28, 2026
- 8-K · Executive departureSep 8, 2026
- SCHEDULE 13G/A · SEC filingAug 13, 2026
- 10-Q · SEC filingAug 5, 2026
- 8-K · SEC filingAug 5, 2026
Get alerts when MIRM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days